Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia.

Bernd Jilma1, Christian Joukhadar, Ulla Derhaschnig

  • 1Department of Clinical Pharmacology-TARGET, University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. bernd.jilma@univie.ac.at

Clinical Science (London, England : 1979)
|January 28, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lidocaine Versus Amiodarone in Patients With Shockable Out-of-Hospital Cardiac Arrest: A Target Trial Emulation.

Critical care medicine·2026
Same author

Targeted Degradation of NETs in Lupus with DNASE1L3 Deficiency.

The New England journal of medicine·2026
Same author

Recombinant human diamine oxidase prevents histamine-induced hypoxia, shock and death in guinea pigs.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same author

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
Same author

Endovascular thrombectomy with or without intravenous thrombolysis in large-vessel ischemic stroke: an updated meta-analysis.

Scientific reports·2026
Same author

Effects of an early restrictive versus liberal fluid strategy on long-term patient-centered outcomes in sepsis-induced hypotension: an open-label, randomized controlled trial.

American journal of respiratory and critical care medicine·2026

Statins do not reduce circulating adhesion molecules (cAM) in hypercholesterolemic patients. Even with significant cholesterol reduction, levels of E-selectin, ICAM-1, and VCAM-1 did not decrease after three months of therapy.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Pharmacology

Background:

  • Adhesion molecules (AMs) play a key role in atherosclerosis development.
  • The relationship between hypercholesterolemia and AM expression is not fully understood.
  • It remains unclear if cholesterol-lowering therapies impact AM levels.

Purpose of the Study:

  • To investigate the effect of three different statins on plasma levels of circulating adhesion molecules (cAM).
  • To determine if statin therapy reduces cAM in hypercholesterolemic patients.
  • To assess the impact of significant low-density lipoprotein cholesterol reduction on cAM.

Main Methods:

  • A randomized clinical trial involving 75 hypercholesterolemic patients.
  • Three-month treatment with standard doses of atorvastatin, simvastatin, and pravastatin.

Related Experiment Videos

  • Measurement of plasma levels of circulating E-selectin, ICAM-1, and VCAM-1 before and after statin therapy.

    • Main Results:

    • None of the statins significantly lowered plasma cAM levels.
    • Pooled analysis showed non-significant increases in cE-selectin, cICAM-1, and cVCAM-1.
    • cAM levels remained unchanged even in patients with >50% reduction in LDL cholesterol.

    Conclusions:

    • Three months of statin therapy does not decrease circulating adhesion molecule levels in moderate hypercholesterolemia.
    • Cholesterol normalization does not appear to reduce AM levels within this timeframe.
    • Further research may be needed to explore longer-term effects or different therapeutic strategies.